Spots Global Cancer Trial Database for Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Official Title: A Phase III Trial of External Beam of Radiotherapy +/- Total Androgen Suppression for High Risk Clinically Organ-Confined Prostate Cancer

Study ID: NCT00116220

Conditions

Prostate Cancer

Interventions

Flutamide (Eulexin) and Lupron or Zoladex

External Beam Radiotherapy

Study Description

Brief Summary: This clinical study was to determine if the use of 6 months of total androgen suppression (hormonal therapy) when added to radiation therapy for localized-high risk prostate cancer would improve overall survival.

Detailed Description: This was a randomized study comparing external beam radiation therapy with total androgen ablation for 6 months with radiation therapy alone. Drugs were given 2 months prior, 2 months during, and 2 months after radiation therapy. Eulexin and Lupron or Zoladex was used in this study.